Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$172.48
-2.01-1.15%
At close: -
$172.48
0.000.00%
After Hours: 4:33 PM EDT
Comments
Loading...
Quest Diagnostics Analyst Ratings and Price Targets | NYSE:DGX | Benzinga
Quest Diagnostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Quest Diagnostics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Piper Sandler
Truist Securities
Barclays
Evercore ISI Group
1calculated from analyst ratings
Analyst Ratings for Quest Diagnostics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/06/2025 | Buy Now | — | JP Morgan | Lisa Gill58% | $180 → $190 | Maintains | Neutral | Get Alert |
| 04/28/2025 | Buy Now | — | Piper Sandler | David Westenberg60% | $180 → $200 | Maintains | Neutral | Get Alert |
| 04/23/2025 | Buy Now | — | Truist Securities | David Macdonald67% | $182 → $190 | Maintains | Hold | Get Alert |
| 04/23/2025 | Buy Now | — | Barclays | Stephanie Davis42% | $175 → $185 | Maintains | Equal-Weight | Get Alert |
| 04/23/2025 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson48% | $175 → $180 | Maintains | In-Line | Get Alert |
| 04/23/2025 | Buy Now | — | Baird | Eric Coldwell80% | $191 → $194 | Maintains | Outperform | Get Alert |
| 04/09/2025 | Buy Now | — | Mizuho | Ann Hynes86% | $178 → $189 | Maintains | Outperform | Get Alert |
| 04/02/2025 | Buy Now | — | Redburn Atlantic | Jamie Clark49% | → $195 | Initiates | → Buy | Get Alert |
| 03/20/2025 | Buy Now | — | Baird | Eric Coldwell80% | $190 → $191 | Maintains | Outperform | Get Alert |
| 03/04/2025 | Buy Now | — | Citigroup | Patrick Donnelly80% | $185 → $185 | Downgrade | Buy → Neutral | Get Alert |
| 02/04/2025 | Buy Now | — | JP Morgan | Lisa Gill58% | $173 → $180 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | — | Mizuho | Ann Hynes86% | $177 → $178 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | — | UBS | Kevin Caliendo71% | $166 → $170 | Maintains | Neutral | Get Alert |
| 02/03/2025 | Buy Now | — | Piper Sandler | David Westenberg60% | $165 → $180 | Reiterates | Neutral → Neutral | Get Alert |
| 01/31/2025 | Buy Now | — | Truist Securities | David Macdonald67% | $172 → $182 | Maintains | Hold | Get Alert |
| 01/31/2025 | Buy Now | — | Barclays | Stephanie Davis42% | $168 → $175 | Maintains | Equal-Weight | Get Alert |
| 01/06/2025 | Buy Now | — | Leerink Partners | Michael Cherny78% | $169 → $174 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/17/2024 | Buy Now | — | Morgan Stanley | Erin Wright 79% | $145 → $172 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/13/2024 | Buy Now | — | B of A Securities | Derik De Bruin84% | $179 → $182 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | — | Jefferies | Tycho Peterson84% | → $185 | Assumes | Buy → Buy | Get Alert |
| 10/28/2024 | Buy Now | — | Piper Sandler | David Westenberg60% | $150 → $165 | Maintains | Neutral | Get Alert |
| 10/24/2024 | Buy Now | — | Mizuho | Ann Hynes86% | $160 → $174 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | — | UBS | Kevin Caliendo71% | $165 → $166 | Maintains | Neutral | Get Alert |
| 10/23/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | $165 → $185 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | — | Barclays | Stephanie Davis42% | $154 → $168 | Maintains | Equal-Weight | Get Alert |
| 10/23/2024 | Buy Now | — | Baird | Eric Coldwell80% | $157 → $182 | Upgrade | Neutral → Outperform | Get Alert |
| 10/07/2024 | Buy Now | — | Truist Securities | David Macdonald67% | $158 → $165 | Maintains | Hold | Get Alert |
| 08/28/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson48% | → $165 | Reinstates | → In-Line | Get Alert |
| 08/27/2024 | Buy Now | — | Barclays | Stephanie Davis42% | $144 → $154 | Maintains | Equal-Weight | Get Alert |
| 07/29/2024 | Buy Now | — | Piper Sandler | David Westenberg60% | $145 → $150 | Maintains | Neutral | Get Alert |
| 07/24/2024 | Buy Now | — | Baird | Eric Coldwell80% | $153 → $154 | Maintains | Neutral | Get Alert |
| 07/15/2024 | Buy Now | — | Truist Securities | David Macdonald67% | $150 → $158 | Maintains | Hold | Get Alert |
| 07/10/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | $145 → $165 | Upgrade | Neutral → Buy | Get Alert |
| 07/05/2024 | Buy Now | — | Baird | Eric Coldwell80% | $145 → $153 | Maintains | Neutral | Get Alert |
| 05/30/2024 | Buy Now | — | JP Morgan | Lisa Gill58% | $152 → $155 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | — | Barclays | Stephanie Davis42% | $138 → $144 | Maintains | Equal-Weight | Get Alert |
| 04/24/2024 | Buy Now | — | Citigroup | Patrick Donnelly80% | $135 → $145 | Maintains | Neutral | Get Alert |
| 04/24/2024 | Buy Now | — | UBS | Kevin Caliendo71% | $139 → $146 | Maintains | Neutral | Get Alert |
| 04/24/2024 | Buy Now | — | Truist Securities | David Macdonald67% | $145 → $150 | Maintains | Hold | Get Alert |
| 04/24/2024 | Buy Now | — | Mizuho | Ann Hynes86% | $150 → $155 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | — | Truist Securities | David Macdonald67% | → $145 | Reiterates | Hold → Hold | Get Alert |
| 02/26/2024 | Buy Now | — | Leerink Partners | Michael Cherny78% | → $135 | Initiates | → Market Perform | Get Alert |
| 02/07/2024 | Buy Now | — | Jefferies | Brian Tanquilut46% | $140 → $155 | Upgrade | Hold → Buy | Get Alert |
| 02/02/2024 | Buy Now | — | Truist Securities | David Macdonald67% | $150 → $145 | Maintains | Hold | Get Alert |
| 12/20/2023 | Buy Now | — | Truist Securities | David Macdonald67% | $145 → $150 | Maintains | Hold | Get Alert |
| 12/12/2023 | Buy Now | — | B of A Securities | Derik De Bruin84% | $140 → $160 | Upgrade | Neutral → Buy | Get Alert |
| 12/11/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $130 → $145 | Maintains | Neutral | Get Alert |
| 12/07/2023 | Buy Now | — | UBS | Kevin Caliendo71% | $135 → $137 | Maintains | Neutral | Get Alert |
| 11/17/2023 | Buy Now | — | JP Morgan | John Stansel68% | $148 → $149 | Maintains | Neutral | Get Alert |
| 11/06/2023 | Buy Now | — | Piper Sandler | David Westenberg60% | $130 → $140 | Maintains | Neutral | Get Alert |
| 10/25/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $142 → $130 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | — | Piper Sandler | David Westenberg60% | $145 → $130 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | — | Morgan Stanley | Ricky Goldwasser79% | $145 → $145 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/29/2023 | Buy Now | — | Piper Sandler | David Westenberg60% | → $145 | Initiates | → Neutral | Get Alert |
| 05/10/2023 | Buy Now | — | Morgan Stanley | Ricky Goldwasser79% | $158 → $145 | Maintains | Equal-Weight | Get Alert |
| 05/02/2023 | Buy Now | — | B of A Securities | Derik De Bruin84% | $166 → $148 | Downgrade | Buy → Neutral | Get Alert |
| 04/03/2023 | Buy Now | — | Citigroup | Patrick Donnelly80% | $125 → $142 | Upgrade | Sell → Neutral | Get Alert |
| 03/17/2023 | Buy Now | — | Truist Securities | David Macdonald67% | $170 → $160 | Maintains | Hold | Get Alert |
| 03/17/2023 | Buy Now | — | Mizuho | Ann Hynes86% | → $165 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | — | Wells Fargo | Timothy Daley54% | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | Buy Now | — | Credit Suisse | Jonathan Yong65% | $143 → $146 | Maintains | Neutral | Get Alert |
| 01/23/2023 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson48% | → $159 | Initiates | → In-Line | Get Alert |
| 01/12/2023 | Buy Now | — | Baird | Eric Coldwell80% | $143 → $154 | Maintains | Neutral | Get Alert |
| 01/06/2023 | Buy Now | — | Morgan Stanley | Ricky Goldwasser79% | $146 → $158 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | Buy Now | — | Mizuho | Ann Hynes86% | $160 → $165 | Maintains | Buy | Get Alert |
| 11/17/2022 | Buy Now | — | Citigroup | Patrick Donnelly80% | $145 → $125 | Downgrade | Neutral → Sell | Get Alert |
| 10/21/2022 | Buy Now | — | Morgan Stanley | Ricky Goldwasser79% | $142 → $146 | Maintains | Equal-Weight | Get Alert |
| 10/21/2022 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $129 → $140 | Maintains | Hold | Get Alert |
| 08/22/2022 | Buy Now | — | Morgan Stanley | Erin Wright72% | → $142 | Assumes | → Equal-Weight | Get Alert |
| 07/22/2022 | Buy Now | — | Mizuho | Ann Hynes86% | $185 → $160 | Maintains | Buy | Get Alert |
| 07/22/2022 | Buy Now | — | Credit Suisse | A.J. Rice69% | $158 → $143 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Quest Diagnostics (DGX) stock?
The latest price target for Quest Diagnostics (NYSE:DGX) was reported by JP Morgan on May 6, 2025. The analyst firm set a price target for $190.00 expecting DGX to rise to within 12 months (a possible 10.16% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Quest Diagnostics (DGX)?
The latest analyst rating for Quest Diagnostics (NYSE:DGX) was provided by JP Morgan, and Quest Diagnostics maintained their neutral rating.
When was the last upgrade for Quest Diagnostics (DGX)?
The last upgrade for Quest Diagnostics Inc happened on January 6, 2025 when Leerink Partners raised their price target to $174. Leerink Partners previously had a market perform for Quest Diagnostics Inc.
When was the last downgrade for Quest Diagnostics (DGX)?
The last downgrade for Quest Diagnostics Inc happened on March 4, 2025 when Citigroup changed their price target from $185 to $185 for Quest Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Quest Diagnostics (DGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quest Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quest Diagnostics was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.
Is the Analyst Rating Quest Diagnostics (DGX) correct?
While ratings are subjective and will change, the latest Quest Diagnostics (DGX) rating was a maintained with a price target of $180.00 to $190.00. The current price Quest Diagnostics (DGX) is trading at is $172.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
